Month: February 2025

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of...

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on...

Turacoz paths itself from a medical writing agency to a technological-driven solution provider for all scientific publications and medical communications requirements

UTRECHT, Netherlands, Feb. 7, 2025 /PRNewswire/ -- With the advent of AI and technological advancements in medical communications, Turacoz recognizes...

Nicolas S. Piuzzi, MD, Presented Kappa Delta Young Investigator Award for Research on Employing Data Analytics to Improve Patient Outcomes

ROSEMONT, Ill., Feb. 7, 2025 /PRNewswire/ -- Nicolas S. Piuzzi, MD, was recognized as the 2025 Kappa Delta Young Investigator Award...

error: Content is protected !!